SCHEMBL20222674

SCHEMBL20222674

CC1(C)c2ccccc2-c2cc3c(cc21)Sc1ccccc1-c1ccccc1-c1ccccc1-c1ccc(-c2cc(-c4ccccc4)nc(-c4ccc(-c5cccnc5)nc4)n2)cc1-3

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDK2 Q15119 3/20 0.34
▸ CYP3A4 P08684 3/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ CYP19A1 P11511 1/20 0.32
▸ CYP11B1 P15538 2/20 0.32
▸ CYP11B2 P19099 2/20 0.32
▸ CYP2A6 P11509 1/20 0.32
▸ HDAC2 Q92769 1/20 0.31
▸ ALDH1A1 P00352 6/20 0.31
▸ POLB P06746 2/20 0.31
▸ NPC1 O15118 2/20 0.31
▸ HPGD P15428 2/20 0.31
▸ KDM4E B2RXH2 2/20 0.31
▸ ACHE P22303 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ L3MBTL1 Q9Y468 1/20 0.31
▸ TSHR P16473 2/20 0.31
▸ MAPT P10636 2/20 0.31
▸ HSD17B10 Q99714 2/20 0.31
▸ RECQL P46063 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20222699 0.97 PDK2 (0.35) PDK2CYP3A4CYP2C9CYP19A1CYP11B1
SCHEMBL20222673 0.97 PDK2 (0.35) PDK2CYP3A4CYP2C9CYP19A1CYP11B1
SCHEMBL20222704 0.93 PDK2 (0.37) PDK2CYP3A4CYP2C9CYP19A1ALDH1A1
SCHEMBL20222765 0.93 PDK2 (0.37) PDK2CYP3A4CYP2C9CYP19A1ALDH1A1
SCHEMBL20222716 0.92 PDK2 (0.38) PDK2CYP3A4CYP2C9CYP19A1CYP11B1
SCHEMBL20222683 0.92 PDK2 (0.38) PDK2CYP3A4CYP2C9CYP19A1CYP11B1
SCHEMBL20845255 0.91 CYP3A4 (0.31) PDK2CYP3A4CYP2C9CYP19A1ALDH1A1
SCHEMBL20222707 0.91 PDK2 (0.39) PDK2CYP3A4CYP2C9CYP19A1CYP11B1
SCHEMBL20845253 0.89 PDK2 (0.31) PDK2CYP3A4CYP19A1CYP2A6
SCHEMBL20845260 0.89 PDK2 (0.31) PDK2CYP3A4CYP2C9CYP19A1CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10693077-B2 Compound and organic electronic device using the same SHANGHAI NICHEM FINE CHEMICAL CO., LTD. (CN) 2020-06-23 — — US disclosed
US-20180155312-A1 COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME NICHEM FINE TECHNOLOGY CO., LTD. (TW) 2018-06-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10693077-B2 Compound and organic electronic device using the same SOD1, SCO2, RCOR3 PDK2 1918/4885CYP3A4 647/4885CYP2C9 181/4885
US-20180155312-A1 COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME SOD1, SCO2, RCOR3 PDK2 1918/4885CYP3A4 647/4885CYP2C9 181/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback